stella
beta
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma — Stella
Recruiting
Back to Carcinoma, Hepatocellular trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
United States
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
Montefiore Medical Center, The Bronx, New York
View full record on ClinicalTrials.gov